America's Top Tradeshow Directory | Events In America
Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

Views: 301

04/17/2012 - 04/18/2012

Washington Marriott Hotel
1221 22nd Street NW
Washington, DC, DC 20037

New Search Send Me More Information
Read Industry Insights

More information about the Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity is listed in the event details below. Log in now or scroll down to get extensive content about the Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity, including audience size, exhibitors, contact names, booth sizes, pricing information and more. And search Events In America for details on other festivals, events, tradeshows, conferences, meetings, seminars, conventions, and fairs.

Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

Join Industry Experts and Regulators to Improve Your Safety Analysis During Drug Development, Analyze and Mitigate Potential Risks, and Explore New Solutions and Approaches to Developing Safe and Effective Medications, including those to treat Type 2 Diabetes Mellitus.

Participate in debate-style presentations and hear commentary and presentations from international industry, academic, and regulatory speakers to help you optimize your cardiovascular safety assessment and improve the development of medications to treat Type 2 Diabetes Mellitus and other diseases.

FEATURES
• This meeting will offer plenary sessions and two tracks – one for Diabetes topics and one for CV safety topics
• Interact with FDA and other regulatory agency participants
• Scientific abstract presentation sessions
• Robust networking opportunities

Event Code:
12009

Don't wait to register for the Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.

All information in Events In America is deemed to be accurate at the time we add it, and we take steps to verify all details and update our records when new information is provided, but as people, events and circumstances change, we caution users to independently confirm all information. EventsInAmerica.com and Events In America LLC make no guarantee of accuracy and assume no liability for inaccurate information.

Advance Networking

How do I show up here?
 

Personal Notes

Add a note here, it is only visible by you.

New Search Send Me More Information
Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity